fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Stroke increase for patients who don’t take meds.

Written by | 16 Jul 2013

New research from a study of over 73,000 patients.  People with high blood pressure, who don’t take their anti-hypertensive drug treatments when they should, have a greatly increased… read more.

Urine test predicts kidney transplant rejection

Written by | 11 Jul 2013

Taken from the NEJM – by Bruce Sylvester – Three biomarkers in the urine of kidney transplant recipients can be used to diagnose and predict transplant rejection, researchers… read more.

High-dose painkillers appear to increase cardio risks, which can be predicted

Written by | 9 Jul 2013

Taken from the Lancet – by Bruce Sylvester – High doses of some non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of major vascular events (non-fatal heart attacks, strokes,… read more.

Finasteride, a hair loss treatment, might also decrease alcohol consumption

Written by | 8 Jul 2013

FDA Highlights by Bruce Sylvester – Researchers report that finasteride appears to reduce alcohol consumption in some men. The results were published online on June 13, 2013 by Alcoholism:… read more.

Bazedoxifene appears to stop growth of breast cancer cells, including those in treatment-resistant tumors

Written by | 5 Jul 2013

FDA Highlights by Bruce Sylvester – Bazedoxifene, approved in Europe to treat osteoporosis, appears to stop the growth of breast cancer cells, even in therapy-resistant tumors, researchers from… read more.

ASCO 2013 – Cancer services in the United Kingdom: Improving nicely

Written by | 25 Jun 2013

by Elizabeth C. Smyth, MB, BCh, MSc, and David Cunningham, MD, FRCP, FMedSci – In 2000, in order to optimise service provision for patients with cancer, 34 “Cancer… read more.

ASCO 2013 – Landmark studies offer new hope for reducing cervical cancer deaths worldwide, first therapies for two rare cancers and treatment advances for breast, brain cancers

Written by | 24 Jun 2013

CHICAGO – Five pivotal studies were released today ahead of the plenary session of the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).

ASCO opens 49th Annual Meeting urging more federal funding for research

Written by | 21 Jun 2013

The American Society of Clinical Oncology (ASCO) kicked off its 49th Annual Meeting with leaders urging all stakeholders in cancer care to vigorously oppose cuts to vital US… read more.

Night shift could age you

Written by | 21 Jun 2013

Human sleeping and waking patterns are largely governed by an internal circadian clock that corresponds closely with the 24-hour cycle of light and darkness. This circadian clock also… read more.

ASCO 2013 – Important advances in treatment for multiple aggressive cancers, and new insight on HPV-related cancer risk

Written by | 20 Jun 2013

CHICAGO – New advances against melanoma, ovarian cancer, and colorectal cancer care were presented today at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)…. read more.

Poor evidence on drug safety in pregnancy leads to deaths

Written by | 14 Jun 2013

Problem is worsening; time to include pregnant women in drug trials, says DTB.  The lack of hard data on the safety and effectiveness of a wide range of… read more.

ASCO 2013 Report – Advanced lung cancer with dysfunctional ALK gene responds to targeted therapy

Written by | 12 Jun 2013

by Bruce Sylvester – Patients with an advanced kind of lung cancer and a dysfunctional ALK gene have achieved better outcomes with the targeted investigative therapy crizotinib rather… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.